Stephane Bancel - Net Worth and Insider Trading
Stephane Bancel Net Worth
The estimated net worth of Stephane Bancel is at least $736 Million dollars as of 2025-03-16. Stephane Bancel is the CEO of Moderna Inc and owns about 21,269,463 shares of Moderna Inc (MRNA) stock worth over $736 Million. Details can be seen in Stephane Bancel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephane Bancel has not made any transactions after 2025-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Stephane Bancel
Stephane Bancel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephane Bancel owns 3 companies in total, including Moderna Inc (MRNA) , Syros Pharmaceuticals Inc (SYRS) , and BG Medicine Inc (BGMD) .
Click here to see the complete history of Stephane Bancel’s form 4 insider trades.
Insider Ownership Summary of Stephane Bancel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MRNA | Moderna Inc | 2025-03-03 | director & Chief Executive Officer |
SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | director |
BGMD | BG Medicine Inc | 2014-06-03 | director |
Stephane Bancel Latest Holdings Summary
Stephane Bancel currently owns a total of 1 stock. Stephane Bancel owns 21,269,463 shares of Moderna Inc (MRNA) as of March 3, 2025, with a value of $736 Million.
Latest Holdings of Stephane Bancel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRNA | Moderna Inc | 2025-03-03 | 21,269,463 | 34.62 | 736,348,809 |
Holding Weightings of Stephane Bancel
Stephane Bancel Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephane Bancel has made a total of 228 transactions in Moderna Inc (MRNA) over the past 5 years, including 1 buys and 227 sells. The most-recent trade in Moderna Inc is the acquisition of 160,314 shares on March 3, 2025, which cost Stephane Bancel around $5 Million.
Insider Trading History of Stephane Bancel
- 1
Stephane Bancel Trading Performance
Stephane Bancel Ownership Network
Ownership Network List of Stephane Bancel
Ownership Network Relation of Stephane Bancel

Stephane Bancel Owned Company Details
What does Moderna Inc do?
Who are the key executives at Moderna Inc?
Stephane Bancel is the director & Chief Executive Officer of Moderna Inc. Other key executives at Moderna Inc include Chief Legal Officer Shannon Thyme Klinger , President Stephen Hoge , and Chief Financial Officer James M Mock .
Moderna Inc (MRNA) Insider Trades Summary
Over the past 18 months, Stephane Bancel made 2 insider transaction in Moderna Inc (MRNA) with a net purchase of 133,963. Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 582,832 shares made by Noubar Afeyan , a net sale of 152,940 shares made by Stephen Hoge , and a net sale of 12,989 shares made by Shannon Thyme Klinger .
In summary, during the past 3 months, insiders sold 0 shares of Moderna Inc (MRNA) in total and bought 160,314 shares, with a net purchase of 160,314 shares. During the past 18 months, 785,923 shares of Moderna Inc (MRNA) were sold and 160,314 shares were bought by its insiders, resulting in a net sale of 625,609 shares.
Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Moderna Inc Insider Transactions
Stephane Bancel Mailing Address
Above is the net worth, insider trading, and ownership report for Stephane Bancel. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephane Bancel's mailing address is: Cambridge Ma 02141.